Protracted venous infusion 5-fluorouracil in combination with subcutaneous interleukin-2 and alpha-interferon in patients with metastatic renal cell cancer - a phase II study.

By Allen M.   Vaughan M.   Webb A.   Johnston S.   Savage P.   Eisen T.   Bates S.   Morre J.   Ahern R.   Gore M.  

Urologic Oncology: Seminars and Original Investigations, Vol. 7, Iss. 2, 2002-03 ,pp. : 83-83

Elsevier

Access to resources Recommend Favorite

A Phase II Study of Continuous Infusional 5-Fluorouracil (5-FU) and Subcutaneous Interleukin-2 (IL-2) in Metastatic Renal Cancer

By Savage P.   Costelna D.   Moore J.   Gore M.E.  

European Journal of Cancer, Vol. 33, Iss. 7, 1997-06 ,pp. : 1149-1151

Elsevier

Access to resources Recommend Favorite

Results of a randomised phase II study of cisplatin plus 5-fluorouracil versus cisplatin plus 5-fluorouracil with -interferon in metastatic pancreatic cancer: an EORTC gastrointestinal tract cancer group trial

By Wagener D.J.T.   Wils J.A.   Kok T.C.   Planting A.   Couvreur M.L.   Baron B.  

European Journal of Cancer, Vol. 38, Iss. 5, 2002-03 ,pp. : 648-653

Elsevier

Access to resources Recommend Favorite

Phase II trial of cisplatin, 5-fluorouracil, and interferon- -2B as first line treatment of advanced urothelial cancer

By Bazarbashi S.   Pai C.   Raja M.A.   Rahal M.   Ezzat A.   Hanash K.  

Urologic Oncology: Seminars and Original Investigations, Vol. 21, Iss. 3, 2003-05 ,pp. : 185-189

Elsevier

Access to resources Recommend Favorite

Chronotherapy with 5-fluorouracil, folinic acid and carboplatin for metastatic colorectal cancer; an interesting therapeutic index in a phase II trial

By Focan C.   Kreutz F.   Focan-Henrard D.   Moeneclaey N.  

European Journal of Cancer, Vol. 36, Iss. 3, 2000-02 ,pp. : 341-347

Elsevier

Access to resources Recommend Favorite